Hemo Organic Ltd. - Research Center
524590 HEMORGANIC Group (X) BSE data
Results
Statement
More
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
-3.78 |
-3.52 |
-3.46 |
-3.40 |
-3.35 |
Secured loans
Unsecured loans
Total
0.92 |
-0.02 |
0.04 |
0.10 |
0.12 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
Less : current liabilities & provisions
Total net current assets
0.92 |
-0.02 |
0.04 |
0.10 |
0.11 |
Miscellaneous expenses not written
Total
0.92 |
-0.02 |
0.04 |
0.10 |
0.12 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
34.66 |
34.66 |
34.66 |
34.66 |
34.66 |